St. Catherine Hospital from Croatia has been named as one of the finalists, and Ruban d’Honneur recipients, in the 2016/17 European Business Awards sponsored by RSM.
It is one of only 110 finalists announced after over 33,000 businesses were engaged in the competition, and was chosen by a panel of independent judges because it displayed the core values of innovation, ethics and success.
The company will now undertake an in depth face-to-face interview, and will find out if it is a winner of one of the 11 categories at a Gala Final on May 4 in Dubrovnik.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8037951-st-catherine-hospital-business-awards/
HMR Weight Management Services Corp. (HMR), a subsidiary of Merck, held its position as a No. 1 “Best Fast Weight-Loss Diet” in the 2017 Best Diets rankings released today by U.S. News & World Report. It’s the second year in a row HMR earned the top spot in the category, which was added to the annual rankings list last year.
“HMR’s highly structured diet and lifestyle change program is designed to help people lose weight quickly while learning the skills they need to keep it off,” said Carol Addy, M.D. MMSc, Chief Medical Officer at HMR. “Fast weight loss without lifestyle change isn’t sustainable. HMR gets fast weight loss, but our true expertise is helping people learn realistic ways to incorporate new healthy behaviors into their everyday lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/8003751-hmr-best-fast-weight-loss-diet-2017/
Allergan plc (NYSE:AGN), a global leader in eye care for nearly 70 years, today unveiled #EyePic, an exciting new online awareness campaign as part of the See America initiative to fight preventable blindness and visual impairment in the United States. #EyePic will use the power of social media to broaden awareness of preventable blindness, promote discussion around eye health and ultimately encourage all Americans to visit their eye doctors for comprehensive eye exams.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134051-allergan-see-america-eyepic-campaign/
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
When a life-changing diagnosis brings moments of uneasiness, a glimmer of hope can make all the difference in bringing solace. As hope comes in many forms, Extended Stay America® hotels, the nation’s largest owner operated hotelier, announced today the launch of the brand’s latest initiative in their continued support for the fight against cancer – the “Give Hope” program. A natural evolution of Extended Stay America’s partnership with the American Cancer Society, the “Give Hope” program provides a platform to raise awareness and funds for pediatric cancer research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8060751-extended-stay-america-give-hope-cancer-research/
Living with type 1 diabetes comes with many unique challenges in all stages of life. For parents of children with the condition, financial, medical and emotional worries can be overwhelming. To help support people with diabetes and those who love them, Lilly Diabetes today announced it will donate $94,000 to the American Diabetes Association (Association) Campership program and $100,000 to the Diabetes Scholars Foundation (Foundation).
To view the multimedia release go to:
http://www.multivu.com/players/English/8004851-lilly-diabetes-scholarship-donations/
After fourteen years, more than $7 million raised and more than 900 wishes granted, Maggiano’s Little Italy® is proud to once again kick off its annual campaign benefiting Make-A-Wish®, a nonprofit organization that grants the wishes of children with life-threatening medical conditions. This year, Maggiano’s is tapping into Guests’ favorite weekly tradition, brunch, and inviting them to “Brunch With A Purpose,” where $1 will be donated to Make-A-Wish for every brunch entrée ordered.
To view the multimedia release go to:
https://www.multivu.com/players/English/8012052-maggianos-make-a-wish-campaign-eatadish4maw/
Are You Suffering from hemorrhoids that don't want to go away? Hemorrhoids are unpleasant and worrisome. Getting rid of hemorrhoids can be difficult. And, you don’t want to strain when having a bowel movement, otherwise they will get bigger. But, do you know if you have hemorrhoids? Do you have some of these symptoms?
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Accurate medical transcription services ensure precise records for infectious disease care, aiding diagnosis, treatment, compliance, and communication.
